398 results on '"Benkelfat, C."'
Search Results
152. Perinatal effects on in vivo measures of human brain serotonin synthesis in adulthood: a 27-year longitudinal study.
- Author
-
Booij L, Benkelfat C, Leyton M, Vitaro F, Gravel P, Lévesque ML, Arseneault L, Diksic M, and Tremblay RE
- Subjects
- Adult, Birth Weight physiology, Brain diagnostic imaging, Carbon Radioisotopes, Female, Heart Diseases etiology, Heart Diseases pathology, Humans, Longitudinal Studies, Lung Diseases etiology, Lung Diseases pathology, Male, Nicotine adverse effects, Positron-Emission Tomography, Pregnancy, Prenatal Exposure Delayed Effects pathology, Stress, Psychological etiology, Stress, Psychological pathology, Surveys and Questionnaires, Tryptophan analogs & derivatives, Brain metabolism, Brain pathology, Obstetric Labor Complications pathology, Serotonin metabolism
- Abstract
There is an increasing evidence that prenatal and early postnatal stressors have life long impacts on physical and mental health problems. Animal studies have shown that this could include enduring changes to brain serotonin neurotransmission. In the present study, we tested whether perinatal adversity in humans has a long-term impact on brain serotonin neurotransmission in adulthood. Twenty-six healthy males, recruited from a 27-year longitudinal study, underwent a positron emission tomography scan with the tracer alpha-[¹¹C]methyl-L-tryptophan (¹¹C-AMT), as an index of serotonin synthesis capacity. The trapping constant is taken as a proxy for the regional 5-HT synthesis. Birth complications, especially a delivery where the fetus showed signs of physiological distress, predicted lower ¹¹C-AMT trapping in the hippocampus and medial orbitofrontal cortex. Lower ¹¹C-AMT trapping in the medial orbitofrontal cortex was also predicted by maternal smoking and lower birth weight. There were no effects of childhood or recent adversity. This is the first human study reporting associations between perinatal adversity and adult ¹¹C-AMT trapping in the hippocampus and medial orbitofrontal cortex. The associations suggest that limbic serotonin pathways may be particularly vulnerable to environmental challenges during the period when they undergo the most prominent neurodevelopmental changes. In combination with other risk factors, perinatal stressors may contribute to increased vulnerability for psychiatric disorders in which serotonin plays a major role., (Copyright © 2011 Elsevier B.V. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
153. The dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers.
- Author
-
Liggins J, Pihl RO, Benkelfat C, and Leyton M
- Subjects
- Adolescent, Adult, Dopamine metabolism, Double-Blind Method, Female, Health, Human Experimentation, Humans, Male, Synaptic Transmission drug effects, Synaptic Transmission physiology, Up-Regulation drug effects, Young Adult, Affect drug effects, Levodopa pharmacology
- Abstract
Dopamine neurotransmission influences approach toward rewards and reward-related cues. The best cited interpretation of this effect proposes that dopamine mediates the pleasure that commonly accompanies reward. This hypothesis has received support in some animal models and a few studies in humans. However, direct assessments of the effect of transiently increasing dopamine neurotransmission have been largely limited to the use of psychostimulant drugs, which elevate brain levels of multiple neurotransmitters in addition to dopamine. In the present study we tested the effect of more selectively elevating dopamine neurotransmission, as produced by administration of the immediate dopamine precursor, L-DOPA (0, 100/25, 200/50 mg, Sinemet), in healthy human volunteers. Neither dose altered positive mood. The results suggest that dopamine neurotransmission does not directly influence positive mood in humans.
- Published
- 2012
- Full Text
- View/download PDF
154. Peripheral SLC6A4 DNA methylation is associated with in vivo measures of human brain serotonin synthesis and childhood physical aggression.
- Author
-
Wang D, Szyf M, Benkelfat C, Provençal N, Turecki G, Caramaschi D, Côté SM, Vitaro F, Tremblay RE, and Booij L
- Subjects
- Adult, Humans, Male, Promoter Regions, Genetic genetics, Thiophenes metabolism, Aggression physiology, Brain metabolism, DNA Methylation genetics, Serotonin metabolism, Serotonin Plasma Membrane Transport Proteins genetics
- Abstract
The main challenge in addressing the role of DNA methylation in human behaviour is the fact that the brain is inaccessible to epigenetic analysis in living humans. Using positron emission tomography (PET) measures of brain serotonin (5-HT) synthesis, we found in a longitudinal sample that adult males with high childhood-limited aggression (C-LHPA) had lower in vivo 5-HT synthesis in the orbitofrontal cortex (OBFC). Here we hypothesized that 5-HT alterations associated with childhood aggression were linked to differential DNA methylation of critical genes in the 5-HT pathway and these changes were also detectable in peripheral white blood cells. Using pyrosequencing, we determined the state of DNA methylation of SLC6A4 promoter in T cells and monocytes isolated from blood of cohort members (N = 25) who underwent a PET scan, and we examined whether methylation status in the blood is associated with in vivo brain 5-HT synthesis. Higher levels of methylation were observed in both T cells and monocytes at specific CpG sites in the C-LHPA group. DNA methylation of SLC6A4 in monocytes appears to be associated more reliably with group membership than T cells. In both cell types the methylation state of these CpGs was associated with lower in vivo measures of brain 5-HT synthesis in the left and right lateral OBFC (N = 20) where lower 5-HT synthesis in C-LHPA group was observed. Furthermore, in vitro methylation of the SLC6A4 promoter in a luciferase reporter construct suppresses its transcriptional activity supporting a functional role of DNA methylation in SLC6A4 promoter regulation. These findings indicate that state of SLC6A4 promoter methylation is altered in peripheral white blood cells of individuals with physical aggression during childhood. This supports the relevance of peripheral DNA methylation for brain function and suggests that peripheral SLC6A4 DNA methylation could be a marker of central 5-HT function.
- Published
- 2012
- Full Text
- View/download PDF
155. Effects of lowered serotonin transmission on cocaine-induced striatal dopamine response: PET [¹¹C]raclopride study in humans.
- Author
-
Cox SM, Benkelfat C, Dagher A, Delaney JS, Durand F, Kolivakis T, Casey KF, and Leyton M
- Subjects
- Administration, Intranasal, Adult, Analysis of Variance, Cocaine administration & dosage, Cocaine metabolism, Cocaine-Related Disorders diagnostic imaging, Cocaine-Related Disorders psychology, Corpus Striatum diagnostic imaging, Corpus Striatum drug effects, Dopamine Uptake Inhibitors administration & dosage, Dopamine Uptake Inhibitors metabolism, Female, Humans, Magnetic Resonance Imaging, Male, Positron-Emission Tomography methods, Raclopride pharmacokinetics, Radiopharmaceuticals pharmacokinetics, Tryptophan administration & dosage, Tryptophan deficiency, Tryptophan metabolism, Young Adult, Cocaine pharmacology, Cocaine-Related Disorders metabolism, Corpus Striatum metabolism, Dopamine metabolism, Dopamine Uptake Inhibitors pharmacology, Serotonin metabolism
- Abstract
Background: Low serotonin transmission is thought to increase susceptibility to a wide range of substance use disorders and impulsive traits., Aims: To investigate the effects of lowered serotonin on cocaine-induced (1.0 mg/kg cocaine, self-administered intranasally) dopamine responses and drug craving., Method: In non-dependent cocaine users, serotonin transmission was reduced using the acute tryptophan depletion method. Striatal dopamine responses were measured using positron emission tomography with [(11)C]raclopride., Results: Acute tryptophan depletion increased drug craving and striatal dopamine responses to cocaine. These acute tryptophan depletion-induced increases did not occur in the absence of cocaine., Conclusions: The results suggest that low serotonin transmission can increase dopaminergic and appetitive responses to cocaine. These findings might identify a mechanism by which individuals with low serotonin are at elevated risk for both substance use disorders and comorbid conditions.
- Published
- 2011
- Full Text
- View/download PDF
156. Acute phenylalanine/tyrosine depletion reduces motivation to smoke cigarettes across stages of addiction.
- Author
-
Venugopalan VV, Casey KF, O'Hara C, O'Loughlin J, Benkelfat C, Fellows LK, and Leyton M
- Subjects
- Adolescent, Adult, Behavior, Addictive psychology, Behavior, Addictive therapy, Female, Humans, Male, Phenylalanine deficiency, Smoking psychology, Smoking therapy, Time Factors, Tyrosine deficiency, Young Adult, Behavior, Addictive blood, Motivation physiology, Phenylalanine blood, Smoking blood, Smoking Cessation methods, Tyrosine blood
- Abstract
The neurobiology of tobacco use is poorly understood, possibly in part because the relevant mechanisms might differ depending on past nicotine exposure and degree of addiction. In the present study we investigated whether these factors might affect the role of dopamine (DA). Using the acute phenylalanine/tyrosine depletion method (APTD), DA synthesis was transiently decreased in three groups of abstinent smokers (n=47): (1) early low-frequency smokers, who had smoked a maximum of five cigarettes per day for less than one year, (2) stable low-frequency smokers smoking at the same level as early low-frequency smokers for at least 3 years, and (3) stable high-frequency smokers, who smoked a minimum of 10 or more cigarettes per day for at least 5 years. Motivation to obtain tobacco was measured using a progressive ratio breakpoint schedule for nicotine-containing and de-nicotinized cigarettes. Compared with a nutritionally balanced control mixture, APTD decreased the self-administration of nicotine-containing cigarettes, and this occurred in all three groups of smokers. The results suggest that DA influenced the willingness to sustain effort for nicotine reward, and this was seen in participants at all three levels of cigarette addiction. In the transition from sporadic to addicted use, the role of DA in the motivation to seek drug may change less than previously proposed.
- Published
- 2011
- Full Text
- View/download PDF
157. Brain regional α-[11C]methyl-L-tryptophan trapping in medication-free patients with obsessive-compulsive disorder.
- Author
-
Berney A, Leyton M, Gravel P, Sibon I, Sookman D, Rosa Neto P, Diksic M, Nakai A, Pinard G, Todorov C, Okazawa H, Blier P, Nordahl TE, and Benkelfat C
- Subjects
- Adolescent, Adult, Case-Control Studies, Caudate Nucleus metabolism, Female, Hippocampus metabolism, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Positron-Emission Tomography, Temporal Lobe metabolism, Tryptophan metabolism, Young Adult, Brain metabolism, Obsessive-Compulsive Disorder metabolism, Tryptophan analogs & derivatives
- Abstract
Context: The hypothesis of a serotonin (5-hydroxytryptamine [5-HT]) dysfunction in obsessive-compulsive disorder (OCD) stems largely from the clinical efficacy of 5-HT reuptake inhibitors. Serotonergic abnormalities in the unmedicated symptomatic state, however, remain to be fully characterized., Objective: To investigate brain regional 5-HT synthesis, as indexed by positron emission tomography and the α-[(11)C]methyl-L-tryptophan trapping constant (K*), in treatment-free adults meeting criteria for OCD., Design: Between-group comparison., Setting: Department of Psychiatry and Montreal Neurological Institute, McGill University, and Department of Psychology, McGill University Health Centre, Quebec, Canada., Participants: Twenty-one medication-free patients with OCD (15 men with a mean [SD] age of 33.2 [9.3] years and 6 women with a mean [SD] age of 35.8 [7.1] years) and 21 healthy controls matched for age and sex (15 men with a mean [SD] age of 32.9 [10.1] years and 6 women with a mean [SD] age of 36.5.5 [8.6] years). Main Outcome Measure The α-[(11)C]methyl-L-tryptophan brain trapping constant K*, which was analyzed with Statistical Parametric Mapping (SPM8) and with proportional normalization (extent threshold of 100 voxels with a peak threshold of P ≤ .005)., Results: Compared with healthy controls, the patients with OCD exhibited significantly greater α-[(11)C]methyl-L-tryptophan trapping in the right hippocampus and left temporal gyrus (Brodmann area 20). In the larger subsample of all men, these same differences were also evident, as well as higher K* values in the caudate nucleus. Individual differences in symptom severity correlated positively with K* values sampled from the caudate and temporal lobe of the patients with OCD, respectively. There were no regions where the patients exhibited abnormally low K* values. Volumetric analyses found no morphometric alterations that would account for the group differences., Conclusion: The results support previous reports of greater striatal and temporal lobe activity in patients with OCD than in healthy controls and suggest that these disturbances include a serotonergic component. Previously reported glucose metabolic disturbances in OCD involving the orbitofrontal and cingulate cortices, in comparison, might reflect postsynaptic changes in the serotonergic system.
- Published
- 2011
- Full Text
- View/download PDF
158. The effect of naltrexone on alcohol's stimulant properties and self-administration behavior in social drinkers: influence of gender and genotype.
- Author
-
Setiawan E, Pihl RO, Cox SM, Gianoulakis C, Palmour RM, Benkelfat C, and Leyton M
- Subjects
- Adolescent, Adult, Alcohol Drinking psychology, Cross-Over Studies, Double-Blind Method, Female, Genotype, Humans, Male, Middle Aged, Naltrexone pharmacology, Receptors, Opioid, mu genetics, Receptors, Opioid, mu metabolism, Self Administration, Young Adult, Alcohol Drinking drug therapy, Alcohol Drinking genetics, Naltrexone therapeutic use, Sex Characteristics
- Abstract
Background: Few pharmacological treatments for alcohol dependence are available. Moreover, the best supported treatment, naltrexone hydrochloride, appears to work for only some., Methods: To investigate potential predictors of these differential responses, 40 social drinkers (20 women) were administered 6 days of treatment with naltrexone vs. placebo in a double-blind, counterbalanced, crossover design. At the end of each treatment period, participants received a single dose of their preferred alcoholic beverage followed by the opportunity to work for additional alcohol units using a progressive ratio (PR) breakpoint paradigm. All subjects but one were genotyped for the A118G polymorphism of the mu opioid receptor gene (OPRM1)., Results: Naltrexone decreased the ethanol-induced 'euphoria' to a priming dose of alcohol in two subgroups: (i) in women, and (ii) in subjects with the A118G polymorphism of the mu opioid receptor gene (OPRM1). Naltrexone did not decrease motivation to work for additional alcoholic beverages on the PR task regardless of gender or genotype., Conclusions: The results add to the evidence that naltrexone decreases positive subjective effects of alcohol, with preferential effects in distinct subgroups. Similar effects in heavier drinkers might decrease alcohol use., (Copyright © 2011 by the Research Society on Alcoholism.)
- Published
- 2011
- Full Text
- View/download PDF
159. Recognizing emotions in faces: effects of acute tryptophan depletion and bright light.
- Author
-
aan het Rot M, Coupland N, Boivin DB, Benkelfat C, and Young SN
- Subjects
- Adolescent, Adult, Cross-Over Studies, Deficiency Diseases blood, Deficiency Diseases complications, Double-Blind Method, Female, Humans, Pattern Recognition, Visual, Seasonal Affective Disorder complications, Seasonal Affective Disorder physiopathology, Serotonin physiology, Tryptophan administration & dosage, Tryptophan blood, Young Adult, Deficiency Diseases physiopathology, Emotions, Facial Expression, Phototherapy, Seasonal Affective Disorder therapy, Social Perception, Tryptophan deficiency
- Abstract
In healthy never-depressed individuals, acute tryptophan depletion (ATD) may selectively decrease the accurate recognition of fearful facial expressions. Here we investigated the perception of facial emotions after ATD in more detail. We also investigated whether bright light, which can reverse ATD's mood-lowering effect, can also reverse its effect on the perception of facial emotions. On two separate test days, spent in a room that was either bright (n = 14) or dim (n = 16), healthy never-depressed women completed a facial emotion perception task six hours after ingesting tryptophan-deficient and balanced amino acid mixtures. Treatments were administered double blind and in randomized order using a crossover design. In dim light ATD decreased recognition accuracy of anger, disgust, and surprise. The labeling of fear and sadness was not affected. In bright light no effects of ATD were seen. Bright light was identified as a potential confounding factor in task performance. The effects of ATD on facial emotion perception may be less emotion-specific than thought previously, and occurred in a direction opposite to what might be expected based on theories of mood-congruent bias.
- Published
- 2010
- Full Text
- View/download PDF
160. Effect of D-amphetamine on inhibition and motor planning as a function of baseline performance.
- Author
-
Allman AA, Benkelfat C, Durand F, Sibon I, Dagher A, Leyton M, Baker GB, and O'Driscoll GA
- Subjects
- Adolescent, Adult, Affect drug effects, Blood Pressure drug effects, Cross-Over Studies, Double-Blind Method, Female, Heart Rate drug effects, Humans, Male, Time Factors, Young Adult, Central Nervous System Stimulants pharmacology, Dextroamphetamine pharmacology, Executive Function drug effects
- Abstract
Rationale: Baseline performance has been reported to predict dopamine (DA) effects on working memory, following an inverted-U pattern. This pattern may hold true for other executive functions that are DA-sensitive., Objectives: The objective of this study is to investigate the effect of D: -amphetamine, an indirect DA agonist, on two other putatively DA-sensitive executive functions, inhibition and motor planning, as a function of baseline performance., Methods: Participants with no prior stimulant exposure participated in a double-blind crossover study of a single dose of 0.3 mg/kg, p.o. of D: -amphetamine and placebo. Participants were divided into high and low groups, based on their performance on the antisaccade and predictive saccade tasks on the baseline day. Executive functions, mood states, heart rate and blood pressure were assessed before (T0) and after drug administration, at 1.5 (T1), 2.5 (T2) and 3.5 h (T3) post-drug., Results: Antisaccade errors decreased with D: -amphetamine irrespective of baseline performance (p = 0.025). For antisaccade latency, participants who generated short-latency antisaccades at baseline had longer latencies on D: -amphetamine than placebo, while those with long-latency antisaccades at baseline had shorter latencies on D: -amphetamine than placebo (drug x group, p = 0.04). D: -amphetamine did not affect motor planning. Ratings of mood improved on D: -amphetamine (p < 0.001). Magnitude of D: -amphetamine-induced changes in elation was related to baseline reaction time variability., Conclusions: D: -amphetamine reduced antisaccade error rates in healthy controls, replicating and extending findings with DA agonists in clinical populations. D: -amphetamine had baseline-dependent effects on antisaccade latency, consistent with an inverted-U relationship between performance and DA activity.
- Published
- 2010
- Full Text
- View/download PDF
161. Brain serotonin synthesis in adult males characterized by physical aggression during childhood: a 21-year longitudinal study.
- Author
-
Booij L, Tremblay RE, Leyton M, Séguin JR, Vitaro F, Gravel P, Perreau-Linck E, Lévesque ML, Durand F, Diksic M, Turecki G, and Benkelfat C
- Subjects
- Adult, Brain diagnostic imaging, Emotions, Humans, Longitudinal Studies, Male, Memory, Positron-Emission Tomography, Tryptophan blood, Aggression, Brain metabolism, Serotonin biosynthesis
- Abstract
Background: Adults exhibiting severe impulsive and aggressive behaviors have multiple indices of low serotonin (5-HT) neurotransmission. It remains unclear though whether low 5-HT mediates the behavior or instead reflects a pre-existing vulnerability trait., Methodology/principal Findings: In the present study, positron emission tomography with the tracer alpha-[(11)C]methyl-L-tryptophan ((11)C-AMT) was used to compare 5-HT synthesis capacity in two groups of adult males from a 21-year longitudinal study (mean age +/- SD: 27.1+/-0.7): individuals with a history of childhood-limited high physical aggression (C-LHPA; N = 8) and individuals with normal (low) patterns of physical aggression (LPA; N = 18). The C-LHPA males had significantly lower trapping of (11)C-AMT bilaterally in the orbitofrontal cortex and self-reported more impulsiveness. Despite this, in adulthood there were no group differences in plasma tryptophan levels, genotyping, aggression, emotional intelligence, working memory, computerized measures of impulsivity, psychosocial functioning/adjustment, and personal and family history of mood and substance abuse disorders., Conclusions/significance: These results force a re-examination of the low 5-HT hypothesis as central in the biology of violence. They suggest that low 5-HT does not mediate current behavior and should be considered a vulnerability factor for impulsive-aggressive behavior that may or may not be expressed depending on other biological factors, experience, and environmental support during development.
- Published
- 2010
- Full Text
- View/download PDF
162. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression.
- Author
-
Sequeira A, Mamdani F, Ernst C, Vawter MP, Bunney WE, Lebel V, Rehal S, Klempan T, Gratton A, Benkelfat C, Rouleau GA, Mechawar N, and Turecki G
- Subjects
- Adult, Animals, Humans, Male, Middle Aged, Oligonucleotide Array Sequence Analysis, RNA, Messenger genetics, Rats, Rats, Sprague-Dawley, Reverse Transcriptase Polymerase Chain Reaction, Brain metabolism, Depressive Disorder, Major genetics, Gene Expression Profiling, Glutamic Acid metabolism, Suicide, gamma-Aminobutyric Acid metabolism
- Abstract
Background: Most studies investigating the neurobiology of depression and suicide have focused on the serotonergic system. While it seems clear that serotonergic alterations play a role in the pathogenesis of these major public health problems, dysfunction in additional neurotransmitter systems and other molecular alterations may also be implicated. Microarray expression studies are excellent screening tools to generate hypotheses about additional molecular processes that may be at play. In this study we investigated brain regions that are known to be implicated in the neurobiology of suicide and major depression are likely to represent valid global molecular alterations., Methodology/principal Findings: We performed gene expression analysis using the HG-U133AB chipset in 17 cortical and subcortical brain regions from suicides with and without major depression and controls. Total mRNA for microarray analysis was obtained from 663 brain samples isolated from 39 male subjects, including 26 suicide cases and 13 controls diagnosed by means of psychological autopsies. Independent brain samples from 34 subjects and animal studies were used to control for the potential confounding effects of comorbidity with alcohol. Using a Gene Ontology analysis as our starting point, we identified molecular pathways that may be involved in depression and suicide, and performed follow-up analyses on these possible targets. Methodology included gene expression measures from microarrays, Gene Score Resampling for global ontological profiling, and semi-quantitative RT-PCR. We observed the highest number of suicide specific alterations in prefrontal cortical areas and hippocampus. Our results revealed alterations of synaptic neurotransmission and intracellular signaling. Among these, Glutamatergic (GLU) and GABAergic related genes were globally altered. Semi-quantitative RT-PCR results investigating expression of GLU and GABA receptor subunit genes were consistent with microarray data., Conclusions/significance: The observed results represent the first overview of global expression changes in brains of suicide victims with and without major depression and suggest a global brain alteration of GLU and GABA receptor subunit genes in these conditions.
- Published
- 2009
- Full Text
- View/download PDF
163. Striatal dopamine responses to intranasal cocaine self-administration in humans.
- Author
-
Cox SM, Benkelfat C, Dagher A, Delaney JS, Durand F, McKenzie SA, Kolivakis T, Casey KF, and Leyton M
- Subjects
- Basal Ganglia diagnostic imaging, Cocaine pharmacokinetics, Female, Humans, Hydrocortisone blood, Male, Phenylalanine blood, Positron-Emission Tomography, Putamen diagnostic imaging, Putamen metabolism, Raclopride administration & dosage, Raclopride metabolism, Receptors, Dopamine D2 metabolism, Self Administration, Tyrosine blood, Young Adult, Administration, Intranasal, Basal Ganglia metabolism, Cocaine administration & dosage, Cocaine pharmacology, Dopamine metabolism
- Abstract
Background: The effect of self-administered cocaine on extracellular dopamine (DA) levels has not been measured in humans., Methods: Ten nondependent cocaine users underwent positron emission tomography [11C]raclopride scans following intranasal self-administration of cocaine hydrochloride (1.0 mg/kg) and placebo powder., Results: Compared with placebo, intranasal cocaine self-administration decreased [11C]raclopride binding values in the ventral limbic striatum and putamen. Individual differences in the magnitude of the [11C]raclopride response in the ventral striatum were predicted by lifetime histories of stimulant drug use., Conclusions: The results suggest that 1) intranasal cocaine self-administration increases synaptic DA levels in human striatum and 2) prior use of stimulant drugs on the street is associated with progressively greater cocaine-induced DA responses. These dopaminergic effects might influence susceptibility to drug-seeking behavior and the progression to substance abuse.
- Published
- 2009
- Full Text
- View/download PDF
164. MicroPET imaging of 5-HT 1A receptors in rat brain: a test-retest [18F]MPPF study.
- Author
-
Aznavour N, Benkelfat C, Gravel P, Aliaga A, Rosa-Neto P, Bedell B, Zimmer L, and Descarries L
- Subjects
- Animals, Brain anatomy & histology, Cats, Humans, Injections, Male, Positron-Emission Tomography, Radioactivity, Rats, Time Factors, Brain diagnostic imaging, Brain metabolism, Piperazines administration & dosage, Pyridines administration & dosage, Receptor, Serotonin, 5-HT1A metabolism
- Abstract
Purpose: Earlier studies have shown that positron emission tomography (PET) imaging with the radioligand [(18)F]MPPF allows for measuring the binding potential of serotonin 5-hydroxytryptamine(1A) (5-HT(1A)) receptors in different regions of animal and human brain, including that of 5-HT(1A) autoreceptors in the raphe nuclei. In the present study, we sought to determine if such data could be obtained in rat, with a microPET (R4, Concorde Microsystems)., Methods: Scans from isoflurane-anaesthetised rats (n = 18, including six test-retest) were co-registered with magnetic resonance imaging data, and binding potential, blood to plasma ratio and radiotracer efflux were estimated according to a simplified reference tissue model., Results: Values of binding potential for hippocampus (1.2), entorhinal cortex (1.1), septum (1.1), medial prefrontal cortex (1.0), amygdala (0.8), raphe nuclei (0.6), paraventricular hypothalamic nucleus (0.5) and raphe obscurus (0.5) were comparable to those previously measured with PET in cats, non-human primates or humans. Test-retest variability was in the order of 10% in the larger brain regions (hippocampus, medial prefrontal and entorhinal cortex) and less than 20% in small nuclei such as the septum and the paraventricular hypothalamic, basolateral amygdaloid and raphe nuclei., Conclusions: MicroPET brain imaging of 5-HT(1A) receptors with [(18)F]MPPF thus represents a promising avenue for investigating 5-HT(1A) receptor function in rat.
- Published
- 2009
- Full Text
- View/download PDF
165. CTN-194 (PICCO): design of a trial of citalopram for the prevention of depression and its consequences in HIV-hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy.
- Author
-
Klein MB, Cooper C, Brouillette MJ, Sheehan NL, Benkelfat C, Annable L, Weston F, Kraus D, and Singer J
- Subjects
- Canada, Depression etiology, Double-Blind Method, Drug Therapy, Combination, HIV Infections drug therapy, Hepatitis C drug therapy, Humans, Interferon alpha-2, Psychometrics, Recombinant Proteins, Sample Size, Severity of Illness Index, Treatment Outcome, Antidepressive Agents, Second-Generation therapeutic use, Antiviral Agents therapeutic use, Citalopram therapeutic use, Depression drug therapy, HIV Infections psychology, Hepatitis C psychology, Interferon-alpha therapeutic use, Ribavirin therapeutic use
- Abstract
Hepatitis C (HCV)-related end stage liver disease is a primary cause of morbidity and mortality in people with HIV. Despite this, co-infected patients have low rates of HCV treatment initiation and completion. This is in large part due to the risk of pegylated-interferon alpha (PEG-IFN-alpha)-related neuropsychiatric complications. We describe the design of a multicentre randomized, placebo-controlled trial that evaluates whether antidepressant prophylaxis is superior to early detection and treatment of depression in increasing the successful completion of HCV therapy. Seventy-six HIV+ adults with chronic HCV infection requiring therapy and with no contraindications to PEG-IFN-alpha/ribavirin will be randomized in a 1:1 ratio to receive citalopram or placebo starting three weeks prior to HCV treatment. A novel aspect of the trial design is the built-in management of emergent depression while maintaining the blinded treatment assignment. This will permit the comparison of prophylactic versus therapeutic use of citalopram. The primary outcome is the average proportion of prescribed PEG-IFN-alpha and ribavirin doses taken per month at weeks 12 and 24, and will be compared between treatment arms. The study will also compare the development of moderate-to-severe depression between treatment arms. A unique feature of this trial will be the use of Telepsychiatry to standardize observer-administered neuropsychiatric evaluations. Assessments of anxiety, quality of life, and adherence to therapy, as well as pathogenetic studies of neuropsychiatric side effects, will be conducted. Intention-to-treat analyses using random regression modeling will be employed to analyze longitudinal data on prescribed PEG-IFN-alpha and ribavirin doses. Survival analyses will be used to compare the time to the development of depression between the two arms. Effective prevention of a broad range of neuropsychiatric symptoms by citalopram has the potential to diminish PEG-IFN-alpha associated morbidity and consequently, allow a greater number of patients to complete full therapy.
- Published
- 2008
- Full Text
- View/download PDF
166. Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers.
- Author
-
Sibon I, Benkelfat C, Gravel P, Aznavour N, Costes N, Mzengeza S, Booij L, Baker G, Soucy JP, Zimmer L, and Descarries L
- Subjects
- Administration, Oral, Adult, Autoreceptors drug effects, Autoreceptors metabolism, Brain diagnostic imaging, Brain drug effects, Double-Blind Method, Humans, Male, Piperazines, Pyridines, Receptor, Serotonin, 5-HT1A metabolism, Reference Values, Antidepressive Agents, Second-Generation pharmacology, Fluorine Radioisotopes pharmacokinetics, Fluoxetine pharmacology, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Positron-Emission Tomography, Raphe Nuclei diagnostic imaging, Raphe Nuclei drug effects, Receptor, Serotonin, 5-HT1A drug effects
- Abstract
Background: Brain serotonin-1A (5-HT(1A)) autoreceptors internalize when activated by agonist or by their endogenous ligand, serotonin. This positron-emission tomography (PET) study tested the hypothesis that 5-HT(1A) autoreceptor internalization might be indexed in vivo by a decrease in the specific binding of the 5-HT(1A) radioligand, 4-[18F]fluoro-N-[2-[1-(2-methoxyphenyl)-1 piperazinyl]ethyl-N-2-pyridinyl-benzamide ([(18)F]MPPF), in the dorsal raphe nucleus (DRN) of healthy adult men administered a single oral dose of the selective serotonin reuptake inhibitor, fluoxetine., Methods: [(18)F]MPPF binding potential was measured in the DRN and other brain regions endowed with 5-HT(1A) receptors in eight healthy volunteers, 5 hours after the randomized, double-blind administration of fluoxetine (20 mg) or placebo., Results: In every subject, [(18)F]MPPF binding potential was decreased in the DRN only (44% +/- 22 SD), in response to fluoxetine., Conclusions: Imaging the functional state of 5-HT(1A) autoreceptors (i.e., internalization) in the human brain, using [(18)F]MPPF/PET, may represent a promising avenue for investigating the neurobiology of serotonin-related disorders and notably of major depression.
- Published
- 2008
- Full Text
- View/download PDF
167. Estrogen administration negatively alters mood following monoaminergic depletion and psychosocial stress in postmenopausal women.
- Author
-
Newhouse PA, Dumas J, Hancur-Bucci C, Naylor M, Sites CK, Benkelfat C, and Young SN
- Subjects
- Aged, Aged, 80 and over, Analysis of Variance, Double-Blind Method, Drug Administration Schedule, Estradiol blood, Estrogens blood, Female, Food, Formulated, Humans, Immunoassay, Middle Aged, Neuropsychological Tests, Pain Measurement, Postmenopause physiology, Postmenopause psychology, Psychiatric Status Rating Scales, Affect drug effects, Biogenic Monoamines blood, Estradiol administration & dosage, Estrogens administration & dosage, Postmenopause drug effects, Stress, Psychological complications
- Abstract
Differences in the rates of affective disorders between women and men may relate to gender differences in gonadal steroid levels such as estrogen that have effects on brain monoamines important to mood regulation. Changes in estrogen secretion patterns during the perimenopause and menopause may be relevant to the increased risk for affective symptoms at that time. This study examined whether 17beta-estradiol (E2) administration can modify the mood effects of experimental psychosocial stress following acute monoamine depletion in postmenopausal women. Subjects consisted of 15 normal postmenopausal women (PMW) (ages 67.1+/-11.2 years) blindly placed on either oral placebo or E2 (1 mg/day for 1 month, then 2 mg/day for 2 months). At the end of the 3-month treatment phase, subjects participated in three blinded depletion challenges in which they ingested each of three amino-acid mixtures: deficient in tryptophan, deficient in phenylalanine/tyrosine, or nutritionally balanced. After 5 h, subjects performed the Trier Social Stress Test (TSST), followed by mood and anxiety ratings. E2-treated subjects exhibited a significant increase in negative mood and anxiety after the TSST compared to placebo-treated women. These effects were independent of monoamine depletion and were not manifest before the TSST or at baseline. Exogenous estrogen administration in PMW may alter or modulate emotional reactivity to stressful events and may alter the sensitivity of emotional regulation. This modulation appears to be independent of alterations in monoaminergic neurotransmission. The dose of estrogen used after menopause may be important in determining the effects of gonadal steroids on emotional regulation.
- Published
- 2008
- Full Text
- View/download PDF
168. The role of dopamine in alcohol self-administration in humans: individual differences.
- Author
-
Barrett SP, Pihl RO, Benkelfat C, Brunelle C, Young SN, and Leyton M
- Subjects
- Adult, Amino Acids administration & dosage, Analysis of Variance, Dopamine Agents administration & dosage, Double-Blind Method, Heart Rate drug effects, Humans, Levodopa administration & dosage, Male, Phenylalanine deficiency, Self Administration, Tyrosine deficiency, Alcohol Drinking metabolism, Alcohol Drinking psychology, Dopamine metabolism, Ethanol administration & dosage, Individuality
- Abstract
Objective: To clarify dopamine's role in alcohol self-administration in a heterogeneous sample of drinkers using acute phenylalanine/tyrosine depletion (APTD)., Methods: Sixteen men with variable drinking histories were characterized on their ethanol-induced cardiac response, a marker previously proposed to index dopamine system reactivity and vulnerability to alcohol abuse. During separate sessions participants were administered (i) a nutritionally balanced (BAL) amino acid (AA) mixture, (ii) a mixture lacking the dopamine precursors, phenylalanine and tyrosine, and (iii) APTD followed by the dopamine precursor, L-DOPA. Five hours after AA administration, participants could earn units of alcohol using a progressive ratio breakpoint task., Results: Alcohol self-administration was reduced in the APTD and APTD+L-DOPA conditions relative to the BAL condition. In both cases the changes were predicted by ethanol-induced cardiac change., Conclusions: The motivation to drink is likely regulated by more than one neurobiological mechanism. Individual differences in cardiac responsivity to ethanol might provide a peripheral marker of responsiveness to pharmacological manipulations of dopamine.
- Published
- 2008
- Full Text
- View/download PDF
169. An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study.
- Author
-
Berney A, Nishikawa M, Benkelfat C, Debonnel G, Gobbi G, and Diksic M
- Subjects
- Adrenergic beta-Antagonists pharmacology, Adrenergic beta-Antagonists therapeutic use, Adult, Affect drug effects, Aged, Antidepressive Agents therapeutic use, Citalopram therapeutic use, Depressive Disorder, Major drug therapy, Depressive Disorder, Major metabolism, Depressive Disorder, Major psychology, Double-Blind Method, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Pindolol pharmacology, Pindolol therapeutic use, Positron-Emission Tomography, Psychiatric Status Rating Scales, Selective Serotonin Reuptake Inhibitors therapeutic use, Tryptophan blood, Antidepressive Agents pharmacology, Citalopram pharmacology, Radiopharmaceuticals, Serotonin biosynthesis, Selective Serotonin Reuptake Inhibitors pharmacology, Tryptophan analogs & derivatives
- Abstract
The antidepressant selective serotonin transporter inhibitors (SSRIs) are clinically active after a delay of several weeks. Indeed, the rapid increase of serotonin (5-HT) caused by SSRIs, stimulates the 5-HT(1A) autoreceptors, which exert a negative feedback on the 5-HT neurotransmission. Only when autoreceptors are desensitized, can SSRIs exert their therapeutic activity. The 5-HT(1A) receptor antagonist pindolol has been used to accelerate the clinical effects of antidepressant by preventing the negative feedback. Using the alpha-[(11)C]methyl-L-tryptophan/positron emission tomography (PET), the goal of the present double-blind, randomized study was to compare the changes in alpha-[(11)C]methyl-L-tryptophan trapping, an index of serotonin synthesis, in patients suffering from unipolar depression treated with the SSRI citalopram (20 mg/day) plus placebo versus patients treated with citalopram plus pindol (7.5 mg/day). PET and Hamilton depression rating scale (HDRS-17) were performed at baseline, and after 10 and 24 days of antidepressant treatment. Results show that the combination citalopram plus pindol, compared to citalopram alone shows a more rapid and greater increase of an index of 5-HT synthesis in prefrontal cortex (BA 9). This research is the first human PET study demonstrating that, after 24 days, the combination SSRIs plus pindolol produces a greater increase of the metabolism of serotonin in the prefrontal cortex, an area associated to depressive symptoms.
- Published
- 2008
- Full Text
- View/download PDF
170. No association between the DRD3 Ser9Gly polymorphism and schizophrenia.
- Author
-
Fathalli F, Rouleau GA, Xiong L, Tabbane K, Benkelfat C, Deguzman R, Zoltan D, Lal S, D'cruz S, and Joober R
- Subjects
- Adult, Antipsychotic Agents therapeutic use, Case-Control Studies, Diagnostic and Statistical Manual of Mental Disorders, Family, Female, Genetic Linkage, Genetic Markers, Genetic Predisposition to Disease genetics, Genotype, Glycine genetics, Haplotypes genetics, Homozygote, Humans, Male, Pedigree, Polymorphism, Single Nucleotide, Psychiatric Status Rating Scales, Schizophrenia diagnosis, Schizophrenia drug therapy, Serine genetics, White People genetics, Gene Frequency, Polymorphism, Genetic, Receptors, Dopamine D3 genetics, Schizophrenia genetics
- Abstract
Objective: To investigate the association between a Ser9Gly polymorphism of the dopamine D3 receptor gene (DRD3) and schizophrenia., Methods: 408 schizophrenic patients and 172 control subjects were compared with regard to their DRD3 Ser9Gly genotypic and allelic frequencies. In addition, we carried out a family-based association study including 183 pedigrees (472 subjects) using the transmission disequilibrium test (TDT)., Results: No significant differences of genotype or homozygosity distribution were identified between patients and controls. When patients were stratified according to gender, response to treatment, age at onset, no significant differences were observed. Neither allele A (Ser), or G (Gly) were preferentially transmitted from parents to affected offspring., Conclusion: The hypothesis that the DRD3 Ser9Gly polymorphism plays a predisposing role in schizophrenia is not supported by this study.
- Published
- 2008
- Full Text
- View/download PDF
171. Bright light exposure during acute tryptophan depletion prevents a lowering of mood in mildly seasonal women.
- Author
-
aan het Rot M, Benkelfat C, Boivin DB, and Young SN
- Subjects
- Adolescent, Adult, Amino Acids administration & dosage, Amino Acids blood, Amino Acids pharmacology, Cross-Over Studies, Double-Blind Method, Female, Humans, Light, Psychiatric Status Rating Scales, Seasonal Affective Disorder metabolism, Seasons, Sleep drug effects, Affect physiology, Phototherapy, Seasonal Affective Disorder therapy, Tryptophan deficiency
- Abstract
We investigated the influence of bright light exposure on the mood-lowering effect of acute tryptophan depletion (ATD). Mildly seasonal healthy young women without a personal or family history of psychiatric disorders remained in either dim or bright light during two test days. Tryptophan-deficient and nutritionally balanced amino acid mixtures were administered in counterbalanced order. Mood state was assessed using the Profile of Mood States (POMS) and Visual Analogue Scales (VAS). In dim light, ATD decreased POMS scores across most subscales, indicating a worsening of mood. In bright light, mood was unaffected by ATD. Thus, bright light blocked the worsening of mood caused by ATD. This was also observed on the positive mood VAS. These results indicate a direct, immediate interaction between bright light and serotonin function. Bright light might help protect against ATD-induced mood change by increasing serotonin above the threshold level below which there is a lowering of mood.
- Published
- 2008
- Full Text
- View/download PDF
172. The effect of genetic variation of the serotonin 1B receptor gene on impulsive aggressive behavior and suicide.
- Author
-
Zouk H, McGirr A, Lebel V, Benkelfat C, Rouleau G, and Turecki G
- Subjects
- Age of Onset, Case-Control Studies, Female, Gene Frequency, Genotype, Humans, Male, Polymerase Chain Reaction methods, Aggression, Genetic Variation, Impulsive Behavior genetics, Polymorphism, Genetic genetics, Receptor, Serotonin, 5-HT1B genetics, Suicide
- Abstract
Impulsive-aggressive behaviors (IABs) are regarded as possible suicide intermediate phenotypes, mediating the relationship between genes and suicide outcome. In this study, we aimed to investigate the putative relationship between genetic variation at the 5-HT1B receptor gene, which in animal models is involved in impulse-aggression control, IABs, and suicide risk. We investigated the relationship of variation at five 5-HT1B loci and IAB measures in a sample of 696 subjects, including 338 individuals who died by suicide and 358 normal epidemiological controls. We found that variation at the 5-HT1B promoter A-161T locus had a significant effect on levels of IABs, as measured by the Buss-Durkee Hostility Inventory (BDHI). Suicides also differed from controls in distribution of variants at this locus. The A-161T locus, which seems to impact 5-HT1B transcription, could play a role in suicide predisposition by means of mediating impulsive-aggressive behaviors., (2007 Wiley-Liss, Inc.)
- Published
- 2007
- Full Text
- View/download PDF
173. In vivo measurements of brain trapping of C-labelled alpha-methyl-L-tryptophan during acute changes in mood states.
- Author
-
Perreau-Linck E, Beauregard M, Gravel P, Paquette V, Soucy JP, Diksic M, and Benkelfat C
- Subjects
- Adult, Humans, Male, Serotonin biosynthesis, Tryptophan metabolism, Affect physiology, Brain metabolism, Positron-Emission Tomography, Tryptophan analogs & derivatives
- Abstract
Background: Little is known about the specific contribution of serotonin (5-HT) to the neurobiology of emotion and mood in healthy people. In an exploratory study, we sought to investigate the effect of rapid and sustained changes of emotional state on the trapping of 11C-labelled alpha-methyl-L-tryptophan (11C-alphaMtrp) used as a proxy of 5-HT synthesis, using positron emission tomography (PET)., Method: In a within-subject repeated-measure design, participants recalled autobiographical memories to self-induce sadness, happiness and a neutral emotional state during scanning to measure brain trapping of 11C-alphaMtrp. Three separate scan acquisitions, counterbalanced for order across subjects, took place at the McConnell Brain Imaging Center, Montréal., Results: Whole brain analysis revealed positive and negative correlations between experienced levels of emotions and 11C-alphaMtrp trapping in the right anterior cingulate cortex., Conclusion: These findings point to a mechanism whereby state-related changes in a proxy of 5-HT synthesis underscore aspects of the self-regulation of normal mood.
- Published
- 2007
174. Brain regional alpha-[11C]methyl-L-tryptophan trapping, used as an index of 5-HT synthesis, in healthy adults: absence of an age effect.
- Author
-
Rosa-Neto P, Benkelfat C, Sakai Y, Leyton M, Morais JA, and Diksic M
- Subjects
- Adult, Age Factors, Aged, Aged, 80 and over, Brain pathology, Female, Humans, Magnetic Resonance Imaging methods, Male, Middle Aged, Models, Statistical, Positron-Emission Tomography instrumentation, Brain diagnostic imaging, Brain metabolism, Carbon Radioisotopes, Positron-Emission Tomography methods, Serotonin biosynthesis, Tryptophan analogs & derivatives
- Abstract
Purpose: Previous functional neuroimaging studies suggest that selective aspects of the brain serotonin (5-HT) system change during the aging process. Here, we assessed the effects of aging on the brain regional alpha-[(11)C]methyl-L: -tryptophan (alpha-[(11)C]MTrp) trapping rate constant (K*; microl.g(-1).min(-1)), which, with certain assumptions, could be taken as a proxy of 5-HT synthesis., Methods: Thirty-six healthy right-handed subjects had positron emission tomography (PET) scans following injection with alpha-[(11)C]MTrp [18 males aged 46.6 +/- 22.2 years (range 20-80 years) and 18 females aged 33.0 +/- 15.5 years (range 20-80 years)]. The trapping rate constant, K*, was calculated with the graphical method for irreversible ligands using the sinus-venous input function. A priori selected volumes of interest (VOIs) were defined using an automatic algorithm., Results: VOI analysis showed no correlation between age and brain regional K* values. As reported by others, significant age-related reductions of gray matter were observed in the thalamus and frontal and cingulate cortices; even with partial volume correction there was still no significant relationship between K* and age. Further exploratory SPM voxelwise correlation between age and alpha-[(11)C]MTrp trapping, using p = 0.05 (uncorrected), as well as voxel-based morphometry, was in agreement with the VOI analysis., Conclusion: The dissociation between age-related changes in brain anatomy and this index of serotonin synthesis suggests independent mechanisms underlying the normal aging process.
- Published
- 2007
- Full Text
- View/download PDF
175. Effect of tryptophan hydroxylase-2 gene variants on suicide risk in major depression.
- Author
-
Lopez de Lara C, Brezo J, Rouleau G, Lesage A, Dumont M, Alda M, Benkelfat C, and Turecki G
- Subjects
- Adolescent, Adult, Aggression psychology, Depressive Disorder, Major psychology, Family, Female, Genetic Predisposition to Disease genetics, Humans, Impulsive Behavior genetics, Impulsive Behavior psychology, Linkage Disequilibrium, Male, Pedigree, Phenotype, Polymorphism, Single Nucleotide, Risk Factors, Suicide psychology, Depressive Disorder, Major enzymology, Depressive Disorder, Major genetics, Genetic Variation, Suicide statistics & numerical data, Tryptophan Hydroxylase genetics
- Abstract
Background: Suicide and depressive disorders are strongly associated, yet not all depressed patients commit suicide. Genetic factors may partly explain this difference. We investigated whether variation at the tryptophan hydroxylase-2 (TPH2) gene and its 5' upstream region may predispose to suicide in major depressive disorder (MDD) and whether this predisposition is mediated by impulsive-aggressive behaviors (IABs)., Methods: We genotyped 14 single nucleotide polymorphisms (SNPs) in 259 depressed subjects, 114 of which committed suicide while depressed. Phenotypic assessments were carried out by means of proxy-based interviews. Single-marker and haplotype association analyses were conducted. Differences in behavioral and personality traits according to genotypic variation were investigated, as well as genetic and clinical predictors of suicide., Results: We found two upstream and two intronic SNPs associated with suicide. No direct effect of these variants was observed on IABs. However, a slight association with reward dependence scores was found. Controlling for suicide risk factors, two SNPs (rs4448731 and rs4641527) significantly predicted suicide, along with cluster B personality disorders and family history of suicide., Conclusions: The TPH2 gene and its 5' upstream region variants may be involved in the predisposition to suicide in MDD; however, our findings do not support the role of IABs as mediators.
- Published
- 2007
- Full Text
- View/download PDF
176. Mood stability during acute stimulator challenge in Parkinson's disease patients under long-term treatment with subthalamic deep brain stimulation.
- Author
-
Berney A, Panisset M, Sadikot AF, Ptito A, Dagher A, Fraraccio M, Savard G, Pell M, and Benkelfat C
- Subjects
- Female, Functional Laterality, Humans, Male, Middle Aged, Mood Disorders diagnosis, Treatment Outcome, Deep Brain Stimulation methods, Mood Disorders etiology, Parkinson Disease psychology, Parkinson Disease therapy, Subthalamic Nucleus physiology
- Abstract
Acute and chronic behavioral effects of subthalamic stimulation (STN-DBS) for Parkinson's disease (PD) are reported in the literature. As the technique is relatively new, few systematic studies on the behavioral effects in long-term treated patients are available. To further study the putative effects of STN-DBS on mood and emotional processing, 15 consecutive PD patients under STN-DBS for at least 1 year, were tested ON and OFF stimulation while on or off medication, with instruments sensitive to short-term changes in mood and in emotional discrimination. After acute changes in experimental conditions, mood core dimensions (depression, elation, anxiety) and emotion discrimination processing remained remarkably stable, in the face of significant motor changes. Acute stimulator challenge in long-term STN-DBS-treated PD patients does not appear to provoke clinically relevant mood effects.
- Published
- 2007
- Full Text
- View/download PDF
177. Conditioned dopamine release in humans: a positron emission tomography [11C]raclopride study with amphetamine.
- Author
-
Boileau I, Dagher A, Leyton M, Welfeld K, Booij L, Diksic M, and Benkelfat C
- Subjects
- Adult, Carbon Radioisotopes, Humans, Male, Protein Binding drug effects, Protein Binding physiology, Receptors, Dopamine metabolism, Amphetamine pharmacology, Conditioning, Psychological physiology, Dopamine metabolism, Positron-Emission Tomography methods, Raclopride metabolism
- Abstract
Studies in laboratory rodents suggest that previously neutral stimuli repeatedly paired with the administration of drugs of abuse can acquire the ability to increase striatal dopamine release. This conditioned neurochemical response is believed to prompt drug seeking in animals and has been hypothesized to contribute to drug craving and relapse in substance abusers. In the present study, we used positron emission tomography and [11C]raclopride to investigate whether amphetamine-predictive stimuli can elicit striatal dopamine release in humans. Nine healthy male volunteers received a capsule containing amphetamine tablets (0.3 mg/kg) on three separate occasions approximately every other day (mean +/- SD, 2.25 +/- 1.13 d apart) in the same environment (scanner suite). At least 2 weeks later, the amphetamine was switched to a placebo of identical appearance and given in the same environmental context. [11C]Raclopride binding to dopamine D(2/3) receptors was assessed after exposure to the first amphetamine-containing pill, after placebo administration, and during a control (no pill) scan. Relative to the control scan, amphetamine administration decreased [11C]raclopride binding potential by 22% in the ventral striatum and 11% in the putamen. Placebo also decreased [11C]raclopride binding potential in the ventral striatum and did so with the same amplitude as amphetamine (23%). These results suggest that cues associated with amphetamine increase dopamine transmission, providing evidence that this system is involved in reward prediction in humans.
- Published
- 2007
- Full Text
- View/download PDF
178. Acute prefrontal cortex TMS in healthy volunteers: effects on brain 11C-alphaMtrp trapping.
- Author
-
Sibon I, Strafella AP, Gravel P, Ko JH, Booij L, Soucy JP, Leyton M, Diksic M, and Benkelfat C
- Subjects
- Adult, Blinking, Brain Mapping methods, Carbon Radioisotopes, Electrophysiology, Female, Functional Laterality, Heart Rate, Humans, Image Processing, Computer-Assisted, Interviews as Topic, Male, Positron-Emission Tomography, Prefrontal Cortex physiology, Reference Values, Serotonin physiology, Affect, Prefrontal Cortex anatomy & histology, Prefrontal Cortex diagnostic imaging, Transcranial Magnetic Stimulation methods
- Abstract
High-frequency repetitive transcranial magnetic stimulation (rTMS) of the left dorsolateral prefrontal cortex (LDLPFC) is a technique with purported efficacy as a treatment for major depression. Here, we assessed in vivo, in healthy volunteers, the effect of acute rTMS of the LDLPFC, relative to the stimulation of the left occipital cortex (LOC), on brain regional serotonin synthesis capacity, using the [(11)C]-alpha-methyl-tryptophan ((11)C-alphaMtrp)/PET method. Ten subjects were studied twice, once following rTMS of the LDLPFC and once following rTMS of the LOC in a randomized counterbalanced order. Three blocks of 15 trains of 10 Hz rTMS were delivered 10 min apart. Behavioural and autonomic measures were recorded before and after each rTMS session. Comparisons of TMS-related changes in regional normalized brain uptake and trapping of (11)C-alphaMtrp (K*) values were carried out using SPM99. Statistically significant regional differences were identified on the basis of an extent threshold of 50 voxels, with a peak threshold of p=0.005 uncorrected. Behavioural and autonomic measures were unaffected by rTMS. Relative to LOC stimulation, LDLPFC rTMS was associated with marked changes in normalized K* in limbic areas, with significantly lower values in the left parahippocampal gyrus (BA 28) and the right insula (BA 13), and higher values in the right cingulate gyrus (BA 31) and cuneus (BA 18). These findings indicate that acute rTMS of the LDLPFC in healthy volunteers modulates aspects of tryptophan/5-HT metabolism in limbic areas. Such adaptive changes may contribute to the mechanism of action of prefrontal rTMS in major depression.
- Published
- 2007
- Full Text
- View/download PDF
179. An examination of DSM-IV depressive symptoms and risk for suicide completion in major depressive disorder: a psychological autopsy study.
- Author
-
McGirr A, Renaud J, Seguin M, Alda M, Benkelfat C, Lesage A, and Turecki G
- Subjects
- Adult, Appetite, Attention, Body Weight, Comorbidity, Decision Making, Depression diagnosis, Depressive Disorder, Major diagnosis, Fatigue psychology, Female, Guilt, Humans, Male, Middle Aged, Personality Assessment, Quebec, Retrospective Studies, Risk Factors, Sleep Initiation and Maintenance Disorders psychology, Depression psychology, Depressive Disorder, Major psychology, Diagnostic and Statistical Manual of Mental Disorders, Suicide psychology
- Abstract
Background: It is unclear whether certain DSM-IV depressive symptoms are more prevalent among individuals who die in the context of a major depressive episode and those who do not, whether this is associated with proximal or distal suicide risk, and whether depressive symptoms cluster to indicate suicide risk., Method: A psychological autopsy method with best informants was used to investigate DSM-IV depressive symptoms among 156 suicides who died in the context of a major depressive episode and 81 major depressive controls., Results: Suicides' depressive symptoms were more likely to include weight or appetite loss, insomnia, feelings of worthlessness or inappropriate guilt as well as recurrent thoughts of death or suicidal ideation. Fatigue and difficulties concentrating or indecisiveness were less prevalent among depressed suicides. These associations were independent of concomitant axis I and II psychopathology. The concomitant presence of (a) fatigue as well as impaired concentration or indecisiveness and (b) weight or appetite gain and hypersomnia was associated with decreased suicide risk. Inter-episode symptom concordance suggests that insomnia is an immediate indicator of suicide risk, while weight or appetite loss and feelings of worthlessness or guilt are not., Limitations: This study employed proxy-based interviews., Conclusions: We found that discrete DSM-IV depressive symptoms and clusters of depressive symptoms help differentiate depressed individuals who die by suicide and those who do not. Moreover, some DSM-IV depressive symptoms are associated with an immediate risk for suicide, while others may result from an etiology of depression common to suicide without directly increasing suicide risk.
- Published
- 2007
- Full Text
- View/download PDF
180. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.
- Author
-
Boileau I, Dagher A, Leyton M, Gunn RN, Baker GB, Diksic M, and Benkelfat C
- Subjects
- Administration, Oral, Adult, Affect drug effects, Affect physiology, Attention drug effects, Attention physiology, Basal Ganglia diagnostic imaging, Basal Ganglia drug effects, Behavior, Addictive metabolism, Behavior, Addictive psychology, Brain Mapping, Carbon Radioisotopes metabolism, Carbon Radioisotopes pharmacokinetics, Caudate Nucleus diagnostic imaging, Caudate Nucleus drug effects, Caudate Nucleus metabolism, Central Nervous System Stimulants administration & dosage, Dextroamphetamine administration & dosage, Dopamine Antagonists pharmacokinetics, Dose-Response Relationship, Drug, Follow-Up Studies, Humans, Impulsive Behavior metabolism, Impulsive Behavior psychology, Longitudinal Studies, Male, Motor Activity physiology, Putamen diagnostic imaging, Putamen drug effects, Putamen metabolism, Raclopride pharmacokinetics, Receptors, Dopamine drug effects, Receptors, Dopamine metabolism, Basal Ganglia metabolism, Central Nervous System Stimulants pharmacology, Dextroamphetamine pharmacology, Dopamine metabolism, Dopamine Antagonists metabolism, Motor Activity drug effects, Positron-Emission Tomography statistics & numerical data, Raclopride metabolism
- Abstract
Context: In animals, repeated exposure to stimulant drugs leads to an enhanced drug-induced psychomotor response and increased dopamine release. This phenomenon, known as sensitization, may confer vulnerability to drug addiction or drug-induced psychosis in humans. A similar phenomenon, referred to as endogenous sensitization, is also believed to play a role in the emergence of positive symptoms in patients with schizophrenia., Objective: To determine whether behavioral and neurochemical sensitization occur in healthy individuals after limited exposure to amphetamine in the laboratory., Design: Open-label, 1-year follow-up of repeated amphetamine administration in healthy volunteers., Setting: Department of Psychiatry, McGill University, and McConnell Brain Imaging Center, Montreal Neurological Institute., Participants: Ten healthy men (mean +/- SD age, 25.8 +/- 1.8 years)., Intervention: Three single doses of amphetamine (dextroamphetamine sulfate, 0.3 mg/kg by mouth) were administered on days 1, 3, and 5., Main Outcome Measures: Using positron emission tomography and [11C]raclopride, we measured dopamine release in response to amphetamine on the first exposure (day 1) and 14 days and 1 year after the third exposure., Results: The initial dose of amphetamine caused dopamine release in the ventral striatum (a reduction in [11C]raclopride binding). Consistent with a sensitization-like phenomenon, 14 and 365 days after the third dose of amphetamine there was a greater psychomotor response and increased dopamine release (a greater reduction in [11C]raclopride binding), relative to the initial dose, in the ventral striatum, progressively extending to the dorsal caudate and putamen. A high novelty-seeking personality trait and self-rating assessments indicating impulsivity predicted proneness to sensitization., Conclusions: Sensitization to stimulants can be achieved in healthy men in the laboratory. This phenomenon is associated with increased dopamine release and persists for at least 1 year.
- Published
- 2006
- Full Text
- View/download PDF
181. Lack of effect of acute dopamine precursor depletion in nicotine-dependent smokers.
- Author
-
Casey KF, Benkelfat C, Young SN, and Leyton M
- Subjects
- Adult, Dopamine Agents administration & dosage, Humans, Levodopa administration & dosage, Male, Pain Measurement methods, Phenylalanine deficiency, Self Administration, Surveys and Questionnaires, Time Factors, Tyrosine deficiency, Diet, Protein-Restricted methods, Dopamine physiology, Tobacco Use Disorder physiopathology, Tobacco Use Disorder psychology, Tobacco Use Disorder therapy
- Abstract
Rationale: Nicotine increases dopamine (DA) release but its role in nicotine dependence remains unclear., Objective: To assess the role of DA in nicotine craving and self-administration using acute phenylalanine/tyrosine depletion (APTD)., Methods: Fifteen nicotine-dependent men ingested, a minimum of 3days apart, a nutritionally balanced amino acid (AA) mixture (BAL), a mixture deficient in the catecholamine precursors, phenylalanine and tyrosine, and APTD followed by the immediate DA precursor, L-DOPA. Beginning 3h after ingestion of the AA mixture, subjects smoked 4 cigarettes. Craving, mood, and other aspects of subjective state were assessed with self-report scales. Smoking puff topography was measured with a computerized flowmeter., Results: APTD did not change smoking puff topography, cigarette craving, or subjective effects of smoking., Conclusions: The findings suggest that in nicotine-dependent smokers craving for cigarettes, subjective effects of nicotine, and the self-administration of freely available cigarettes are largely unrelated to acute changes in DA neurotransmission.
- Published
- 2006
- Full Text
- View/download PDF
182. Gender and risk factors for suicide: evidence for heterogeneity in predisposing mechanisms in a psychological autopsy study.
- Author
-
McGirr A, Séguin M, Renaud J, Benkelfat C, Alda M, and Turecki G
- Subjects
- Adult, Alcoholism diagnosis, Alcoholism epidemiology, Alcoholism psychology, Comorbidity, Depressive Disorder diagnosis, Depressive Disorder epidemiology, Depressive Disorder psychology, Diagnosis, Dual (Psychiatry), Diagnostic and Statistical Manual of Mental Disorders, Female, Humans, Impulsive Behavior diagnosis, Impulsive Behavior epidemiology, Impulsive Behavior psychology, Male, Mental Disorders diagnosis, Mental Disorders epidemiology, Mental Disorders psychology, Personality Assessment, Personality Inventory, Prevalence, Psychiatric Status Rating Scales statistics & numerical data, Quebec epidemiology, Risk Factors, Sex Distribution, Sex Factors, Suicide psychology, Suicide statistics & numerical data
- Abstract
Objective: It is unclear whether clinical and behavioral suicide risk factors, identified primarily among men, can be extended to women. We therefore explored sex differences in psychopathology and personality variants among suicide completers., Method: Using the psychological autopsy method, we compared personality variants and the prevalence of psychopathology as a function of sex among 351 consecutive suicides in a large, urban community. Psychiatric diagnoses were obtained using the Structured Clinical Interview for DSM-IV-TR Axis I Disorders and the Structured Clinical Interview for DSM-IV Axis II Personality Disorders, and measures of impulsive aggression, temperament, and character were administered. Subsequently, we carried out secondary analyses between male and female suicides matched 2:1 for age, current depression, and number of lifetime depressive episodes. The study was conducted from late 2000 to 2005., Results: Females were less likely to meet criteria for current and lifetime alcohol abuse, but those who did were less likely than males to have concurrent depression. On average, females were less impulsive, yet similar proportions of males and females were highly impulsive and impulsivity was associated with alcohol abuse irrespective of gender. Females were more likely to meet criteria for lifetime anxiety disorders; these were associated with nonviolent suicide methods, irrespective of gender., Conclusions: Despite a lower prevalence among females, high levels of impulsivity and alcohol abuse appear to be valid risk factors for both sexes. Researchers should focus on females for the identification of other suicide mediators.
- Published
- 2006
- Full Text
- View/download PDF
183. Association study of the trinucleotide repeat polymorphism within SMARCA2 and schizophrenia.
- Author
-
Sengupta S, Xiong L, Fathalli F, Benkelfat C, Tabbane K, Danics Z, Labelle A, Lal S, Krebs MO, Rouleau G, and Joober R
- Subjects
- Case-Control Studies, Genetic Markers, Humans, Polymorphism, Restriction Fragment Length, Schizophrenia genetics, Transcription Factors genetics, Trinucleotide Repeats
- Abstract
Background: Brahma (BRM) is a key component of the multisubunit SWI/SNF complex, a complex which uses the energy of ATP hydrolysis to remodel chromatin. BRM contains an N-terminal polyglutamine domain, encoded by a polymorphic trinucleotide (CAA/CAG) repeat, the only known polymorphism in the coding region of the gene (SMARCA2). We have examined the association of this polymorphism with schizophrenia in a family-based and case/control study. SMARCA2 was chosen as a candidate gene because of its specific role in developmental pathways, its high expression level in the brain and some evidence of its association with schizophrenia spectrum disorder from genome-wide linkage analysis., Results: Family-based analysis with 281 complete and incomplete triads showed that there is no significant preferential transmission of any of the alleles to the affected offspring. Also, in the case/control analysis, similar allele and genotype distributions were observed between affected cases (n = 289) and unaffected controls (n = 273) in each of three Caucasian populations studied: French Canadian, Tunisian and other Caucasians of European origin., Conclusion: Results from our family-based and case-control association study suggest that there is no association between the trinucleotide repeat polymorphism within SMARCA2 and schizophrenia.
- Published
- 2006
- Full Text
- View/download PDF
184. Lack of effects on core obsessive-compulsive symptoms of tryptophan depletion during symptom provocation in remitted obsessive-compulsive disorder patients.
- Author
-
Berney A, Sookman D, Leyton M, Young SN, and Benkelfat C
- Subjects
- Adult, Analysis of Variance, Double-Blind Method, Female, Humans, Male, Psychiatric Status Rating Scales, Secondary Prevention, Treatment Outcome, Tryptophan metabolism, Cognitive Behavioral Therapy methods, Obsessive-Compulsive Disorder therapy, Selective Serotonin Reuptake Inhibitors therapeutic use, Tryptophan deficiency
- Abstract
Background: Pharmacological evidence support that enhancement of serotonin (5-HT) neurotransmission is critical for treatment efficacy in obsessive-compulsive disorder (OCD). Surprisingly, acute tryptophan depletion (ATD), a procedure known to reduce 5-HT neurotransmission, carried out in remitted OCD patients on selective serotonin reuptake inhibitors (SSRIs) failed to worsen obsessive-compulsive (OC) symptoms. We hypothesized that the putative symptom exacerbation resulting from ATD would only be observed during symptom provocation but not at rest., Methods: Double-blind placebo-controlled ATD study conducted in 16 OCD patients with stable improvement under either SSRI (n = 8) or specialized cognitive behavior therapy alone (n = 8), coupled with gradual symptom provocation, performed 5 hours after drink ingestion., Results: Acute tryptophan depletion markedly reduced total and free plasma tryptophan levels but did not significantly increase obsessions or compulsions at rest or following symptom provocation. However, subjective distress in response to triggering situations was significantly higher during ATD; significant mood lowering was also present during ATD., Conclusions: These results are consistent with the view that relapses in OC core symptoms in remitted OCD patients may not depend solely on short-term changes in presynaptic 5-HT availability. In contrast to its apparent lack of effect on core OC symptoms, ATD affected the patient's mood and distress level resulting from provocation.
- Published
- 2006
- Full Text
- View/download PDF
185. alpha-[11C]Methyl-L-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attempters.
- Author
-
Leyton M, Paquette V, Gravel P, Rosa-Neto P, Weston F, Diksic M, and Benkelfat C
- Subjects
- Adult, Brain Mapping, Depressive Disorder diagnostic imaging, Depressive Disorder psychology, Female, Humans, Image Interpretation, Computer-Assisted, Male, Positron-Emission Tomography, Psychiatric Status Rating Scales, Tryptophan pharmacokinetics, Prefrontal Cortex diagnostic imaging, Prefrontal Cortex metabolism, Radiopharmaceuticals pharmacokinetics, Suicide, Attempted psychology, Tryptophan analogs & derivatives
- Abstract
Low serotonin neurotransmission is thought to increase vulnerability to suicidal behavior. To test this hypothesis, we measured brain regional serotonin synthesis, as indexed by PET and alpha-[(11)C]methyl-L-tryptophan trapping, in 10 patients who had made a high-lethality suicide attempt and 16 healthy controls. Compared to healthy controls, suicide attempters had reduced normalized alpha-[(11)C]methyl-L-tryptophan trapping in orbital and ventromedial prefrontal cortex. alpha-[(11)C]Methyl-L-tryptophan trapping in these regions correlated negatively with suicide intent. Low serotonin synthesis in the prefrontal cortex might lower the threshold for suicidal behavior.
- Published
- 2006
- Full Text
- View/download PDF
186. STin2 variant and family history of suicide as significant predictors of suicide completion in major depression.
- Author
-
Lopez de Lara C, Dumais A, Rouleau G, Lesage A, Dumont M, Chawky N, Alda M, Benkelfat C, and Turecki G
- Subjects
- Adolescent, Adult, Case-Control Studies, Chi-Square Distribution, Depressive Disorder, Major mortality, Family Health, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Personality genetics, Personality Tests standards, Polymorphism, Genetic genetics, Predictive Value of Tests, Quebec epidemiology, Risk Factors, Tandem Repeat Sequences genetics, Depressive Disorder, Major genetics, Gene Frequency genetics, Serotonin Plasma Membrane Transport Proteins genetics, Suicide statistics & numerical data
- Abstract
Background: Suicide is the most serious outcome of major depression, yet not all depressed patients will commit suicide. Genes, along with other factors, might account for this difference. Serotonergic alterations have been observed in suicide and depression and impulsive-aggressive behaviors. Therefore, we aimed to identify predictors of suicide, considering genetic variation at the serotonin transporter (5-HTT) gene., Methods: We investigated the 5-HTT gene-linked polymorphic region (5-HTTLPR) and intron 2 (STin2) variants of this gene and their relationship to behavioral and clinical risk factors for suicide in a sample of depressed suicides (n =106) and depressed control subjects (n =152), diagnosed by means of proxy-based interviews., Results: We found a significant association of suicide completion with having at least one copy of the STin2 10 allele [chi(2)(1) = 10.833, p = .002]. No differences were found for the 5-HTTLPR variable number of tandem repeats. After controlling for behavioral and clinical risk factors for suicide, the STin2 variant remained a significant predictor of suicide in major depression when jointly considered with a family history of suicide (odds ratio 5.560, 95% confidence interval 1.057-29.247)., Conclusions: The STin2 locus might account, at least in part, for the observed familial aggregation of suicidal behavior. These results should be further explored in families where clustering of suicidal behavior is observed.
- Published
- 2006
- Full Text
- View/download PDF
187. Implication of SSAT by gene expression and genetic variation in suicide and major depression.
- Author
-
Sequeira A, Gwadry FG, Ffrench-Mullen JM, Canetti L, Gingras Y, Casero RA Jr, Rouleau G, Benkelfat C, and Turecki G
- Subjects
- Acetyltransferases metabolism, Adult, Blotting, Western, Cerebral Cortex metabolism, Chromosome Mapping, Cluster Analysis, Depressive Disorder, Major diagnosis, Gene Expression Profiling statistics & numerical data, Genetic Predisposition to Disease psychology, Genotype, Humans, Immunohistochemistry, Male, Middle Aged, Motor Cortex metabolism, Oligonucleotide Probes, Prefrontal Cortex metabolism, Reverse Transcriptase Polymerase Chain Reaction, Suicide psychology, Acetyltransferases genetics, Depressive Disorder, Major genetics, Genetic Predisposition to Disease genetics, Genetic Variation, Oligonucleotide Array Sequence Analysis statistics & numerical data, Suicide statistics & numerical data
- Abstract
Context: A large body of evidence suggests that predisposition to suicide, an important public health problem, is mediated to a certain extent by neurobiological factors., Objective: To investigate patterns of expression in suicide with and without major depression and to identify new molecular targets that may play a role in the neurobiology of these conditions., Design: Brain gene expression analysis was performed using the Affymetrix HG-U133 chipset in the orbital cortex (Brodmann area [BA] 11), the dorsolateral prefrontal cortex (BA8/9), and motor cortex (BA4). Subsequent studies were carried out in independent samples from adjacent areas to validate positive findings, confirm their relevance at the protein level, and investigate possible effects of genetic variation., Subjects: We investigated 12 psychiatrically normal control subjects and 24 suicide victims, including 16 with and 8 without major depression, in the brain gene expression analysis, validation, and protein studies. The genetic studies included 181 suicide completers and 80 psychiatrically normal controls. All subjects investigated were male and of French Canadian origin., Main Outcome Measures: Gene expression measures from microarray, semiquantitative reverse transcription-polymerase chain reaction, immunohistochemistry, and Western blot analyses., Results: Twenty-six genes were selected because of the consistency of their expression pattern (fold change, >1.3 in either direction [P
- Published
- 2006
- Full Text
- View/download PDF
188. Cocaine craving, euphoria, and self-administration: a preliminary study of the effect of catecholamine precursor depletion.
- Author
-
Leyton M, Casey KF, Delaney JS, Kolivakis T, and Benkelfat C
- Subjects
- Adult, Catecholamines metabolism, Circadian Rhythm drug effects, Cocaine blood, Cocaine-Related Disorders drug therapy, Diet, Protein-Restricted, Dopamine Agents therapeutic use, Dopamine Uptake Inhibitors blood, Dose-Response Relationship, Drug, Drug Interactions, Humans, Levodopa therapeutic use, Male, Phenylalanine deficiency, Phenylalanine metabolism, Self Administration, Time Factors, Tyrosine deficiency, Tyrosine metabolism, Catecholamines deficiency, Cocaine administration & dosage, Cocaine-Related Disorders psychology, Dopamine Uptake Inhibitors administration & dosage, Euphoria drug effects
- Abstract
The authors used the acute phenylalanine-tyrosine depletion (APTD) method to test the effect of transient catecholamine precursor depletion on cocaine craving, euphoria, and self-administration. Eight nondependent, nontreatment-seeking cocaine users self-administered 3 doses of cocaine (0.6, 1.5, 3.0 mg/kg, taken intranasally) following ingestion of (a) a nutritionally balanced amino acid mixture, (b) APTD, and (c) APTD followed by L-dopa/carbidopa (2x100 mg/25 mg). APTD decreased both cue and cocaine-induced drug craving but not euphoria or self-administration. APTD+L-dopa also decreased drug craving, possibly reflecting the ability of L-dopa to transiently decrease dopamine cell firing. Together, these preliminary results suggest that the craving elicited by cocaine and cocaine cues is related to changes in catecholamine neurotransmission. Euphoria and the self-administration of freely available drugs by regular users, in comparison, might be better accounted for by other mechanisms., (Copyright (c) 2006 APA, all rights reserved.)
- Published
- 2005
- Full Text
- View/download PDF
189. Increasing blood oxygen increases an index of 5-HT synthesis in human brain as measured using alpha-[(11)C]methyl-L-tryptophan and positron emission tomography.
- Author
-
Nishikawa M, Kumakura Y, Young SN, Fiset P, Vogelzangs N, Leyton M, Benkelfat C, and Diksic M
- Subjects
- Adolescent, Adult, Brain diagnostic imaging, Brain Mapping, Carbon Radioisotopes, Cerebrovascular Circulation physiology, Female, Humans, Male, Positron-Emission Tomography, Tryptophan analogs & derivatives, Tryptophan metabolism, Tryptophan Hydroxylase metabolism, Up-Regulation physiology, Brain metabolism, Brain Chemistry physiology, Oxygen blood, Oxygen Consumption physiology, Serotonin biosynthesis
- Abstract
The main objective of this investigation was to test the hypothesis that brain serotonin (5-HT) synthesis, as measured by trapping of alpha-[(11)C]methyl-L-tryptophan (alpha-MTrp) using positron emission tomography (PET), can be modulated by changes in blood oxygen. The study involved six healthy participants (three male and three female), who breathed a 15% or 60% oxygen mixture starting 15 min before the injection of tracer and continuing during the entire acquisition period. Participants were injected with up to 12m Ci of alpha-MTrp. Two sets of PET images were acquired while the participants were breathing each of the oxygen mixtures and, after reconstruction, all images were converted into brain functional images illustrating the brain trapping constant K(*) (microL/g/min). The K(*) values were obtained for 12 regions of interest outlined on the magnetic resonance images. The K(*) values obtained at high and low blood oxygen content were compared by paired statistics using Tukey's post hoc correction. As there were no difference in plasma tryptophan concentrations, these K(*) values are directly related to regional 5-HT synthesis. The results showed highly significant increases (50% on average) in brain serotonin synthesis (K(*) values) at high (mean value of 223+/-41 mmHg) relative to low (mean value 77.1+/-7.7 mmHg) blood oxygen levels. This suggests that tryptophan hydroxylase is not saturated with oxygen in the living human brain and that increases in blood oxygen can elevate brain serotonin synthesis.
- Published
- 2005
- Full Text
- View/download PDF
190. Brain regional alpha-[11C]methyl-L-tryptophan trapping correlates with post-mortem tissue serotonin content and [11C]5-hydroxytryptophan accumulation.
- Author
-
Leyton M, Diksic M, and Benkelfat C
- Subjects
- Autoradiography, Female, Humans, Male, Tryptophan metabolism, 5-Hydroxytryptophan metabolism, Brain Chemistry physiology, Serotonin metabolism, Tryptophan analogs & derivatives
- Published
- 2005
- Full Text
- View/download PDF
191. Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men.
- Author
-
Dumais A, Lesage AD, Alda M, Rouleau G, Dumont M, Chawky N, Roy M, Mann JJ, Benkelfat C, and Turecki G
- Subjects
- Adult, Case-Control Studies, Cause of Death, Depressive Disorder, Major diagnosis, Diagnosis, Dual (Psychiatry), Humans, Impulsive Behavior diagnosis, Impulsive Behavior psychology, Logistic Models, Male, Marital Status, Mental Disorders diagnosis, Mental Disorders epidemiology, Parents, Personality Disorders diagnosis, Personality Disorders epidemiology, Personality Disorders psychology, Personality Inventory, Prevalence, Risk Factors, Sex Factors, Substance-Related Disorders diagnosis, Substance-Related Disorders epidemiology, Suicide psychology, Aggression psychology, Depressive Disorder, Major epidemiology, Impulsive Behavior epidemiology, Suicide statistics & numerical data
- Abstract
Objective: Major depression is a major risk factor for suicide. However, not all individuals with major depression commit suicide. Impulsive and aggressive behaviors have been proposed as risk factors for suicide, but it remains unclear whether their effect on the risk of suicide is at least partly explained by axis I disorders commonly associated with suicide, such as major depression. With a case-control design, a comparison of the level of impulsive and aggressive behaviors and the prevalence of associated psychopathology was carried out with control for the presence of primary psychopathology., Method: One hundred and four male suicide completers who died during an episode of major depression and 74 living depressed male comparison subjects were investigated with proxy-based interviews by using structured diagnostic instruments and personality trait assessments., Results: The authors found that current (6-month prevalence) alcohol abuse/dependence, current drug abuse/dependence, and cluster B personality disorders increased the risk of suicide in individuals with major depression. Also, higher levels of impulsivity and aggression were associated with suicide. An analysis by age showed that these risk factors were more specific to younger suicide victims (ages 18-40). A multivariate analysis indicated that current alcohol abuse/dependence and cluster B personality disorder were two independent predictors of suicide., Conclusions: Impulsive-aggressive personality disorders and alcohol abuse/dependence were two independent predictors of suicide in major depression, and impulsive and aggressive behaviors seem to underlie these risk factors. A developmental hypothesis of suicidal behavior, with impulsive and aggressive behaviors as the starting point, is discussed.
- Published
- 2005
- Full Text
- View/download PDF
192. Stability of alpha-[11C]methyl-L-tryptophan brain trapping in healthy male volunteers.
- Author
-
Rosa-Neto P, Diksic M, Leyton M, Mzengeza S, and Benkelfat C
- Subjects
- Adult, Humans, Male, Metabolic Clearance Rate, Middle Aged, Radiopharmaceuticals pharmacokinetics, Reference Values, Reproducibility of Results, Sensitivity and Specificity, Tryptophan pharmacokinetics, Brain diagnostic imaging, Brain metabolism, Brain Mapping methods, Positron-Emission Tomography methods, Serotonin metabolism, Tryptophan analogs & derivatives
- Abstract
Purpose: The purpose of this study was to assess the reproducibility in healthy volunteers of alpha-[11C]methyl-L-tryptophan (alpha[11C]MT) brain trapping imaging with positron emission tomography (PET), using volumes of interest (VOIs) and voxel-based image analysis., Methods: Six right-handed healthy male volunteers (34.3+/-10.9 years) with a negative family history for psychiatric disorders were scanned twice in the resting condition, 22+/-17 days apart. An unbiased semiautomatic segmentation of the brain was used to define VOIs. The trapping constant K* (ml g(-1) min(-1)) for alpha[11C]MT was calculated for the whole brain and seven brain regions using the graphical method for irreversible tracers. In addition, parametric maps of K* were obtained from dynamic scans using the same method. Comparison of test and retest K* functional images was performed using SPM99. Student's paired t statistic was applied for comparisons of alpha[11C]MT brain trapping in a priori selected VOIs., Results: alpha[11C]MT brain trapping in VOIs showed a mean variability 2.6+/-1.8% (0.3-5%) for absolute and 1.5+/-2.1% (1.4-4.1%) for normalized K*. Intraclass correlations between test and retest conditions were 0.61+/-0.34 for absolute K* values and 0.73+/-0.20 for K* values normalized by global mean. SPM99 analysis using a height threshold of p=0.05 (two tailed) and an extent threshold of 100 voxels showed no significant differences between scans., Conclusion: Rest measurements in healthy male volunteers of the trapping constant for alpha[11C]MT, using PET, appeared to be stable during an average interval of 3 weeks.
- Published
- 2005
- Full Text
- View/download PDF
193. Increased prevalence of schizophrenia spectrum disorders in relatives of neuroleptic-nonresponsive schizophrenic patients.
- Author
-
Joober R, Rouleau GA, Lal S, Bloom D, Lalonde P, Labelle A, and Benkelfat C
- Subjects
- Adult, Demography, Drug Tolerance, Family Health, Female, Humans, Magnetic Resonance Imaging methods, Male, Middle Aged, Prevalence, Psychiatric Status Rating Scales, Risk, Schizophrenia classification, Schizophrenia mortality, Schizotypal Personality Disorder classification, Schizotypal Personality Disorder mortality, Antipsychotic Agents therapeutic use, Schizophrenia drug therapy, Schizophrenia epidemiology, Schizophrenic Psychology, Schizotypal Personality Disorder drug therapy, Schizotypal Personality Disorder epidemiology
- Abstract
Objective: It is suggested that schizophrenic patients who respond to neuroleptic medication and those who do not might differ with respect to their pathogenesis. In particular, it has been proposed that genetic factors may contribute to treatment response and/or outcome. In order to test this hypothesis, we compared the pattern of familial aggregation of schizophrenia related disorders in schizophrenic patients who are either responders (R) or nonresponders (NR) to typical neuroleptics., Method: R (n=36) or NR (n=35) patients to typical neuroleptics and healthy controls (n=63) were recruited. At least one key informant relative of each proband was interviewed blind as to the status of the proband using the Family Interview for Genetic Studies. Morbid risk for schizophrenia and cluster A personality disorders and family loading score for schizophrenia were examined in first- and second-degree relatives of these probands., Results: First-degree relatives of NR patients were at a significantly higher risk for schizophrenia (MR=8.84), compared, respectively, to relatives of controls (MR=1.52) or relatives of R patients (MR=2.45). The same pattern was observed in second-degree relatives. Family loading score for schizophrenia in first- and second-degree relatives was significantly higher in NR compared to R patients., Conclusions: Schizophrenic patients who do not respond to typical neuroleptics may suffer from a more familial form of schizophrenia compared to patients who are responders.
- Published
- 2005
- Full Text
- View/download PDF
194. CAA insertion polymorphism in the 3'UTR of Nogo gene on 2p14 is not associated with schizophrenia.
- Author
-
Xiong L, Rouleau GA, Delisi LE, St-Onge J, Najafee R, Rivière JB, Benkelfat C, Tabbane K, Fathalli F, Danics Z, Labelle A, Lal S, and Joober R
- Subjects
- Chi-Square Distribution, Gene Frequency, Genotype, Humans, Mental Status Schedule, Molecular Biology methods, Nogo Proteins, White People, 3' Untranslated Regions, Chromosomes, Human, Pair 2, Genetic Predisposition to Disease, Myelin Proteins genetics, Polymorphism, Genetic, Schizophrenia genetics
- Abstract
The Nogo gene was putatively implicated in schizophrenia based on gene expression and genetic association data. In this study, we attempt to replicate the possible association of the CAA insertion and a nearby TATC deletion with schizophrenia in 204 complete and incomplete triads and in a sample of 462 unrelated cases and 153 controls, all of Caucasian origin. Our genotyping results indicated that neither the trinucleotide insertion polymorphism (CAAins; 43.4% vs. 41.8%, p>0.5) nor the polymorphism-TATC deletion (TATCdel; 49.8% vs. 49.3%, p>0.1) allele frequency is significantly different in patients compared to controls. The homozygous CAAins frequency is not significantly different between patients and controls either (18.0% vs. 15.0%, chi2=0.985, p>0.1). Furthermore, neither CAAins/TATCdel individually, nor the haplotype carrying both CAAins and TATCdel is preferentially transmitted to affected offspring.
- Published
- 2005
- Full Text
- View/download PDF
195. Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression.
- Author
-
Rosa-Neto P, Diksic M, Okazawa H, Leyton M, Ghadirian N, Mzengeza S, Nakai A, Debonnel G, Blier P, and Benkelfat C
- Subjects
- Caudate Nucleus metabolism, Cerebral Cortex metabolism, Depressive Disorder metabolism, Female, Gyrus Cinguli anatomy & histology, Humans, Magnetic Resonance Imaging, Male, Thalamus metabolism, Tomography, Emission-Computed, Single-Photon, Brain metabolism, Carbon Radioisotopes metabolism, Depressive Disorder diagnosis, Gyrus Cinguli metabolism, Serotonin biosynthesis, Tryptophan analogs & derivatives, Tryptophan metabolism
- Abstract
Context: The serotonin hypothesis of depression invokes a relative or absolute deficit of serotonin neurotransmission. Reduced synthesis of serotonin in the brain pathways mediating the expression of mood (ie, the limbic cortex) is a plausible candidate mechanism., Objectives: To measure and compare, using the alpha-[(11)C]methyl-l-tryptophan/positron emission tomography method, the brain trapping constant of alpha-[(11)C]methyl-l-tryptophan (K*, milliliters per gram per minute), an index of serotonin synthesis, in brain areas involved in the regulation of mood in patients with major depression (MD) and age- and sex-matched controls., Design: Between-group comparison., Setting: Department of Psychiatry and Montreal Neurological Institute, McGill University., Participants: Seventeen medication-free outpatients with a current episode of MD (9 women: mean +/- SD age, 41 +/- 11 years; 8 men: mean +/- SD age, 41 +/- 11 years) and 17 controls (9 women: mean +/- SD age, 37 +/- 15 years; 8 men: mean +/- SD age, 32.5 +/- 9.9 years). Main Outcome Measure Normalized K*, normalized to the global mean, was measured in the dorsolateral prefrontal, anterior cingulate, and mesial temporal cortices; the thalamus; and the caudate nucleus., Results: Compared with age- and sex-matched controls, normalized K* was significantly decreased bilaterally in female patients with MD in the anterior cingulate cortex, in the left anterior cingulate cortex in male patients with MD, and in the left mesial temporal cortex in male and female patients with MD (P<.001 for all). Exploratory analyses identified additional patient-control differences for normalized K* (eg, inferior frontal gyrus and superior parietal lobule), most of which, once corrected for 38 multiple comparisons, lost their significance. Morphometric measurements of the cingulate cortex divisions confirmed that the reduction of normalized K* in depressed patients was not attributable to a reduction in gray matter volume. Normalized K* in the anterior cingulate cortex did not correlate with ratings of depression severity collected at the time of scan., Conclusions: Reduction of normalized K*, an index of serotonin synthesis, in parts of the limbic and paralimbic cortices may contribute to the biochemical alterations associated with MD.
- Published
- 2004
- Full Text
- View/download PDF
196. Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men.
- Author
-
Leyton M, Dagher A, Boileau I, Casey K, Baker GB, Diksic M, Gunn R, Young SN, and Benkelfat C
- Subjects
- Adult, Binding Sites, Brain anatomy & histology, Brain metabolism, Brain Mapping, Dextroamphetamine blood, Diet, Protein-Restricted, Dopamine Antagonists pharmacokinetics, Drug Interactions, Humans, Male, Phenylalanine deficiency, Raclopride pharmacokinetics, Statistics as Topic, Tomography, Emission-Computed, Tyrosine deficiency, Brain drug effects, Dextroamphetamine pharmacology, Dopamine metabolism, Dopamine Uptake Inhibitors pharmacology, Phenylalanine metabolism, Tyrosine metabolism
- Abstract
Acute phenylalanine/tyrosine depletion (APTD) has been proposed as a new method to decrease catecholamine neurotransmission safely, rapidly, and transiently. Validation studies in animals are encouraging, but direct evidence in human brain is lacking. In the present study, we tested the hypothesis that APTD would reduce stimulated dopamine (DA) release, as assessed by positron emission tomography (PET) and changes in [(11)C]raclopride binding potential (BP), a measure of DA D2/D3 receptor availability. Eight healthy men received two PET scans, both following d-amphetamine, 0.3 mg/kg, p.o., an oral dose known to decrease [(11)C]raclopride BP in ventral striatum. On the morning before each scan, subjects ingested, in counter-balanced order, an amino-acid mixture deficient in the catecholamine precursors, phenylalanine, and tyrosine, or a nutritionally balanced mixture. Brain parametric images were generated by calculating [(11)C]raclopride BP at each voxel. BP values were extracted from the t-map (threshold: t=4.2, equivalent to p<0.05, Bonferroni corrected) and a priori identified regions of interest from each individual's coregistered magnetic resonance images. Both receptor parametric mapping and region of interest analyses indicated that [(11)C]raclopride binding was significantly different on the two test days in the ventral striatum (peak t=6.31; x=-25, y=-8, and z=0.1). In the t-map defined cluster, [(11)C]raclopride BP values were 11.8+/-11.9% higher during the APTD session (p<0.05). The reduction in d-amphetamine-induced DA release exhibited a linear association with the reduction in plasma tyrosine levels (r=-0.82, p<0.05). Together, the results provide the first direct evidence that APTD decreases stimulated DA release in human brain. APTD may be a suitable new tool for human neuropsychopharmacology research.
- Published
- 2004
- Full Text
- View/download PDF
197. Alcohol promotes dopamine release in the human nucleus accumbens.
- Author
-
Boileau I, Assaad JM, Pihl RO, Benkelfat C, Leyton M, Diksic M, Tremblay RE, and Dagher A
- Subjects
- Adult, Basal Ganglia drug effects, Basal Ganglia metabolism, Central Nervous System Depressants pharmacology, Dopamine Antagonists, Humans, Magnetic Resonance Imaging, Male, Raclopride, Tomography, Emission-Computed, Alcohol Drinking metabolism, Dopamine metabolism, Ethanol pharmacology, Nucleus Accumbens drug effects, Nucleus Accumbens metabolism
- Abstract
Microdialysis experiments in rodents indicate that ethanol promotes dopamine release predominantly in the nucleus accumbens, a phenomenon that is implicated in the reinforcing effects of drugs of abuse. The aim of the present study was to test the hypothesis in humans that an oral dose of ethanol would lead to dopamine release in the ventral striatum, including the nucleus accumbens. Six healthy subjects underwent two [(11)C]raclopride PET scans following either alcohol (1 ml/kg) in orange juice or orange juice alone. Subjective mood changes, heart rate, and blood-alcohol levels were monitored throughout the procedure. Personality traits were evaluated using the tridimensional personality questionnaire. PET images were co-registered with MRI and transformed into stereotaxic space. Statistical parametric maps of [(11)C]raclopride binding potential change were generated. There was a significant reduction in [(11)C]raclopride binding potential bilaterally in the ventral striatum/nucleus accumbens in the alcohol condition compared to the orange juice condition, indicative of increased extracellular dopamine. Moreover, the magnitude of the change in [(11)C]raclopride binding correlated with the alcohol-induced increase in heart rate, which is thought to be a marker of the psychostimulant effects of the drug, and with the personality dimension of impulsiveness. The present study is the first report that, in humans, alcohol promotes dopamine release in the brain, with a preferential effect in the ventral striatum. These findings support the hypothesis that mesolimbic dopamine activation is a common property of abused substances, possibly mediating their reinforcing effects., (Copyright 2003 Wiley-Liss, Inc.)
- Published
- 2003
- Full Text
- View/download PDF
198. Understanding emotion regulation in borderline personality disorder: contributions of neuroimaging.
- Author
-
Johnson PA, Hurley RA, Benkelfat C, Herpertz SC, and Taber KH
- Subjects
- Aspartic Acid metabolism, Borderline Personality Disorder diagnostic imaging, Brain diagnostic imaging, Brain drug effects, Brain Mapping, Choline metabolism, Compulsive Personality Disorder physiopathology, Creatinine metabolism, Depression complications, Depression physiopathology, Electroencephalography methods, Female, Fenfluramine pharmacology, Humans, Magnetic Resonance Imaging methods, Nerve Net physiopathology, Serotonin Agents pharmacology, Tomography, Emission-Computed methods, Tryptophan metabolism, Aspartic Acid analogs & derivatives, Borderline Personality Disorder physiopathology, Brain physiopathology, Emotions physiology
- Published
- 2003
- Full Text
- View/download PDF
199. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior.
- Author
-
Anguelova M, Benkelfat C, and Turecki G
- Subjects
- Alleles, Amino Acid Substitution, Case-Control Studies, Depression genetics, Gene Frequency, Genetic Predisposition to Disease, Genotype, Humans, Polymorphism, Genetic, Receptor, Serotonin, 5-HT1A genetics, Receptor, Serotonin, 5-HT1B genetics, Receptor, Serotonin, 5-HT2A genetics, Serotonin Plasma Membrane Transport Proteins, Carrier Proteins genetics, Membrane Glycoproteins genetics, Membrane Transport Proteins, Nerve Tissue Proteins, Promoter Regions, Genetic genetics, Receptors, Serotonin genetics, Self-Injurious Behavior genetics, Suicide, Suicide, Attempted
- Abstract
The different serotonin (5-HT) receptors, including the serotonin transporter (5-HTT), are excellent candidate genes for suicide and suicidal behavior, and thus, they have been investigated in a large number of allelic association studies. The individual results of these studies have been inconsistent and definite conclusions are difficult to establish. A reliable method for assessing individual studies and generating combined results is provided by systematic reviews using meta-analytical techniques. In this study, we carried out a systematic review of studies investigating 5-HT receptors and the 5-HTT in suicidal behavior. Studies were identified by means of MEDLINE database searches and by scanning reference lists. More than 190 articles were reviewed and 26 met the inclusion criteria. In all, 14 studies investigated six different 5-HT receptor loci and 12 studies investigated the 5-HTT promoter 44 bp insertion/deletion polymorphism. Two specific meta-analyses were carried out, pooling studies investigating the 5-HT2A 102 T/C and the 5-HTT promoter loci that included, respectively, a total of 1599 and 2539 subjects. The combined evidence was significant for association with the 5-HTT locus (Mantel-Haenszel weighted odds ratio (M-H(w) OR)=1.17 CI : 1.04-1.32, P=0.009), but not for the 5-HT2A 102 T/C variant (M-H(w) OR)=1.09 CI : 0.93-1.27, P=0.319). The 5-HTT result was robust and remained significant following sensitivity analysis, suggesting that 5-HTT may play a role in the predisposition to suicide.
- Published
- 2003
- Full Text
- View/download PDF
200. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders.
- Author
-
Anguelova M, Benkelfat C, and Turecki G
- Subjects
- Humans, Serotonin Plasma Membrane Transport Proteins, Carrier Proteins genetics, Membrane Glycoproteins genetics, Membrane Transport Proteins, Mood Disorders genetics, Nerve Tissue Proteins, Receptors, Serotonin genetics
- Abstract
The different 5-HT (serotonin) receptors including the serotonin transporter (5-HTT) are candidate genes for affective disorders such as major depressive disorder (MDD) and bipolar disorder (BD). They have been investigated in a number of allelic association studies where the individual results have been inconsistent, and therefore, definite conclusions are difficult to make. Systematic reviews using meta-analytical techniques are a reliable method for objectively and reproducibly assessing individual studies and generating combined result. This study aimed at reviewing published studies investigating the association between affective disorders (MDD and BD) and variation at genes coding for serotonin receptors and the serotonin transporter. We performed National Library of Medicine database searches to identify potential studies. More than 430 articles were reviewed and 86 studies met the inclusion criteria for participation in our review. Of these, 41 studies investigated 45 different 5-HT receptor variants and 45 studies investigated at least one of two commonly studied 5-HTT polymorphisms in MDD. Many studies investigated the association between MDD and BD with the 5-HT2A 102 T/C, the 5-HTT promoter 44 bp insertion/deletion and the intron 2 VNTR polymorphisms, and thus, these could be pooled using meta-analytic techniques. The overall odds ratio (OR) for the combined individual results was significant for BD and the two 5-HTT polymorphisms: Mantel-Haenszel weighted OR=1.14, CI: 1.03-1.26, P=0.015 for the promoter locus (N=3467) and Mantel-Haenszel Weighted odds ratio OR=1.18, CI: 1.05-1.32, P=0.004 for the VNTR locus (N=3620). However, sensitivity analysis indicated that, in each case, the overall positive association could be mostly attributed to the large effect of one individual study. Therefore, these results suggest that, although promising, further studies are required to assess appropriately the evidence suggesting an association between BD and 5-HTT.
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.